News Desk, AnyTV, New Delhi
Published by: Amit Mandal
Updated Fri, 04 Mar 2022 10:56 PM IST
Summary
According to a research, people who have very low immunity can benefit from additional doses of COVID-19 vaccine.
hear the news
hear the news
University of Singapore research
According to a research published in BMJ, people who have very low immunity may benefit from additional doses of COVID-19 vaccine. Researchers from the National University of Singapore said that after an analysis of 82 research, it has become clear that people who have already reduced immunity or have suddenly decreased, they must take the third dose. In this research, mRNA vaccine was used in 77 cases while viral vector vaccine was used in 16.
Seroconversion has been found to be reduced in people who have reduced immunity after a single dose of the COVID-19 vaccine. Seroconversion is the process of making antibodies after infection or vaccination. This enables the immune system to compete with the virus. It has also been told in research that the immunity of blood cancer patients is significantly reduced compared to solid cancer. Whereas in people who have to undergo an organ transplant, the immunity decreases by 16 times.
Expansion
University of Singapore research
According to a research published in BMJ, people who have very low immunity may benefit from additional doses of COVID-19 vaccine. Researchers from the National University of Singapore said that after an analysis of 82 research, it has become clear that people who have already reduced immunity or have suddenly decreased, they must take the third dose. In this research, mRNA vaccine was used in 77 cases while viral vector vaccine was used in 16.
Seroconversion has been found to be reduced in people who have reduced immunity after a single dose of the COVID-19 vaccine. Seroconversion is the process of making antibodies after infection or vaccination. This enables the immune system to compete with the virus. It has also been told in research that the immunity of blood cancer patients is significantly reduced compared to solid cancer. Whereas in people who have to undergo an organ transplant, the immunity decreases by 16 times.